A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis

Clinical trial NCT00404885 · COMPLETED

Trial details

NCT number: NCT00404885
Sponsor: Lux Biosciences, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Uveitis, Anterior Panuveitis

Start date: 2007-01-01
Primary completion: 2008-11-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.